Khloris Biosciences Patents – Insights & Stats (Updated 2024)

Khloris Biosciences has a total of 13 patents globally, out of which no patents have been granted. Of these 13 patents, more than 76% patents are active. United States of America is where Khloris Biosciences has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Khloris Biosciences.

Khloris Biosciences was founded in the year 2017. Khloris Biosciences is a biotechnology company based in the Bay Area dedicated to revolutionizing medical treatment of cardiovascular.

Do read about some of the most popular patents of Khloris Biosciences which have been covered by us in this article and also you can find Khloris Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Khloris Biosciences patent portfolio.

How many patents does Khloris Biosciences have?

Khloris Biosciences has a total of 13 patents globally. These patents belong to 3 unique patent families. Out of 13 patents, 10 patents are active.

How Many Patents did Khloris Biosciences File Every Year?

Khloris Biosciences Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantKhloris Biosciences Applications FiledKhloris Biosciences Patents Granted
20224
20211
20202
20196

How many Khloris Biosciences patents are Alive/Dead?

Khloris Biosciences Patent Portfolio

How Many Patents did Khloris Biosciences File in Different Countries?

Khloris Biosciences Worldwide Patent Filing

Countries in which Khloris Biosciences Filed Patents

CountryPatents
United States Of America2
Japan1
Europe1
Mexico1
Singapore1
Canada1
Hong Kong (S.A.R.)1
Australia1
India1

Where are Research Centres of Khloris Biosciences Patents Located?

The Research Centre for all the Khloris Biosciences patents is the United States of America.

What Percentage of Khloris Biosciences US Patent Applications were Granted?

Khloris Biosciences (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.

Below are the key stats of Khloris Biosciences patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Khloris Biosciences?

Law FirmTotal ApplicationsSuccess Rate
Hdc Ip Law Llp10%

List of Khloris Biosciences Patents

Khloris Biosciences PatentsTitle
US20230181708A1Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer
US20220387569A1Induced Pluripotent Stem Cell-Based Cancer Vaccines
EP3720482A1Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer
WO2023019000A1Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer
HK40037676AIpsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer
MX2020006944AIpsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer.
IN202047031167AIpsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer
SG11202006160RAIpsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer
AU2018399641A1Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer
CA3087254A1Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer
WO2022256277A1Induced Pluripotent Stem Cell-Based Cancer Vaccines
JP2021509122AIpsc-Based Vaccines As Prophylactic And Therapeutic Treatments For Cancer
WO2019136038A4Ipsc-Based Vaccine As A Prophylactic And Therapeutic Treatment For Cancer

What are Khloris Biosciences key innovation segments?

What Technologies are Covered by Khloris Biosciences?

The chart below distributes patents filed by Khloris Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Khloris Biosciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Khloris Biosciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Khloris Biosciences?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.